French pharmacovigilance survey evaluating the hepatic toxicity of coumarin - PubMed (original) (raw)
French pharmacovigilance survey evaluating the hepatic toxicity of coumarin
M Andréjak et al. Pharmacoepidemiol Drug Saf. 1998 Aug.
Abstract
Synthetic coumarin (benzopyrone) was launched in France in 1988 for the adjuvant therapy of lymphoedema of the upper limb following radiosurgical treatment of breast cancer. Further to the reporting of hepatic reactions, a national survey has been carried out. The survey dealt with 22 cases reported to the pharmacovigilance regional centres and 20 to Knoll France company (five duplicate cases) up to June 1996. Thirty-four cases corresponding to an elevation of ALT over 2N and/or alkaline phosphatase over 1.5N (criteria chosen for selection in this survey) had been taken into account. Among these cases, a causal relationship was considered likely or probable for 15 of them. Two positive rechallenges were reported. The hepatic reactions observed between 2 to 6 months of treatment in two-thirds of the cases (average dose: 90 mg/day; i.e. recommended dose) was essentially cytolytic in 85% of the cases, with jaundice in 14 cases and hyperbilirubinaemia reported in five other cases. In 23 cases (68%), the increase of ALT exceeded 10N. Of the patients 41% were hospitalized. Severe liver failure with encephalopathy justified liver transplantation once and likely led to encephalopathy and fatal evolution in two other cases. The evolution was favourable in the other cases. The drug was prescribed for other uses than the registered indication in more than 50% of these cases. No risk factors could be identified in the survey. This survey provides a strong signal for potential hepatotoxicity of coumarin (likely due to the production of a reactive metabolite in some patients exhibiting a coumarin 7-hydroxylation deficiency).
Copyright 1998 John Wiley & Sons, Ltd.
Similar articles
- Coumarin-Induced Hepatotoxicity: A Narrative Review.
Pitaro M, Croce N, Gallo V, Arienzo A, Salvatore G, Antonini G. Pitaro M, et al. Molecules. 2022 Dec 19;27(24):9063. doi: 10.3390/molecules27249063. Molecules. 2022. PMID: 36558195 Free PMC article. Review. - [Hepatic tolerance of atypical antipsychotic drugs].
Dumortier G, Cabaret W, Stamatiadis L, Saba G, Benadhira R, Rocamora JF, Aubriot-Delmas B, Glikman J, Januel D. Dumortier G, et al. Encephale. 2002 Nov-Dec;28(6 Pt 1):542-51. Encephale. 2002. PMID: 12506267 Review. French. - NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program. National Toxicology Program. Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340. Natl Toxicol Program Tech Rep Ser. 1993. PMID: 12616289 - Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
Conforti A, Magro L, Moretti U, Scotto S, Motola D, Salvo F, Ros B, Leone R. Conforti A, et al. Drug Saf. 2006;29(12):1163-72. doi: 10.2165/00002018-200629120-00007. Drug Saf. 2006. PMID: 17147462 - Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey.
Dumortier J, Cottin J, Lavie C, Guillaud O, Hervieu V, Chambon-Augoyard C, Scoazec JY, Vukusic S, Vial T. Dumortier J, et al. Clin Res Hepatol Gastroenterol. 2017 Sep;41(4):497-501. doi: 10.1016/j.clinre.2017.03.008. Epub 2017 Apr 21. Clin Res Hepatol Gastroenterol. 2017. PMID: 28438569
Cited by
- Combined Risk Assessment of Food-derived Coumarin with in Silico Approaches.
Yamada T, Katsutani N, Maruyama T, Kawamura T, Yamazaki H, Murayama N, Tong W, Yamazoe Y, Hirose A. Yamada T, et al. Food Saf (Tokyo). 2022 Sep 23;10(3):73-82. doi: 10.14252/foodsafetyfscj.D-21-00015. eCollection 2022 Sep. Food Saf (Tokyo). 2022. PMID: 36237397 Free PMC article. - Isolation, Identification and Characterization of Growth Parameters of Pseudomonas putida HSM-C2 with Coumarin-Degrading Bacteria.
Huang S, Wang M, Mao D, Rasool A, Jia C, Yang P, Han L, Yan M. Huang S, et al. Molecules. 2022 Sep 15;27(18):6007. doi: 10.3390/molecules27186007. Molecules. 2022. PMID: 36144743 Free PMC article. - Coumarin-Induced Hepatotoxicity: A Narrative Review.
Pitaro M, Croce N, Gallo V, Arienzo A, Salvatore G, Antonini G. Pitaro M, et al. Molecules. 2022 Dec 19;27(24):9063. doi: 10.3390/molecules27249063. Molecules. 2022. PMID: 36558195 Free PMC article. Review. - [Medicines withdrawn in other countries due to safety concerns: should they continue to be available in the Argentine pharmaceutical market?].
Buschiazzo H, Dorati C, Iusef Venturini N, Cañas M, Urtasun MA, Marin GH, Prozzi GR, Rivadulla PA, Trionfetti M, Mordujovich Buschiazzo P. Buschiazzo H, et al. Rev Fac Cien Med Univ Nac Cordoba. 2022 Sep 16;79(3):241-247. doi: 10.31053/1853.0605.v79.n3.35443. Rev Fac Cien Med Univ Nac Cordoba. 2022. PMID: 36149072 Free PMC article. Spanish.
LinkOut - more resources
Full Text Sources